Venetoclax (ABT-199) is a selective BH3-mimetic Bcl-2 antagonist that is currently used in the clinic for treatment of chronic lymphocytic leukemia patients. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.